|
Archived Press Releases
|
EPA Grants Official Registration for Child-Safe Insect Repellent The advent of Bite Blocker with BioUD™ is timely as consumers have long awaited a DEET-free, child-safe insect repellent and the bugs are on their way. EPA estimates that one-third of Americans use DEET – the active ingredient in popular insect repellents. While EPA has deemed DEET safe for adults, recent reassessments have resulted in new child safety labeling requirements on all products containing the chemical. Biolex Announces Potential to Produce Monoclonal Antibodies with Increased Potency & Efficacy November 28 , 2006-- Biolex Announces Potential to Produce Monoclonal Antibodies with Increased Potency & Efficacy Monoclonal antibodies comprise one of the fastest growing classes of protein therapeutics and are currently being used and developed primarily to treat cancers, autoimmune diseases, infectious diseases and inflammatory diseases. Biolex Therapeutics, an NC State start-up company, announced results publishes in Nature Biotechnology demonstrating the ability of its proprietary LEX System to produce monoclonal antibodies that have enhanced in vitro potency and efficacy.
Pfizer Animal Health Agrees to Acquire Embrex, Inc., the Leader in 'In Ovo' Poultry Vaccine-Delivery Technology November 15, 2006 --Pfizer Animal Health, a division of Pfizer Inc (NYSE: PFE) has agreed to acquire Embrex, Inc. (NASDAQ: EMBX), an international agricultural biotechnology company known for its Inovoject® vaccine-delivery systems, the companies announced today. Founded in 1985, Embrex began as an NC State start up and is now an international agricultural biotechnology company focused on developing and providing in ovo solutions that meet the needs of the global poultry industry.
Nitronex Corporation, an NC State Spin-Out and Leading Developer of GaN-on-Silicon Technology Works with sp3 on Phase II SBIR Award June 27, 2006 --sp3 Diamond Technologies, Inc., a supplier of wafer scale diamond and diamond products for solving thermal management challenges in high-performance applications, announces receipt of a $750,000 Phase II contract from the Missile Defense Agency (MDA) for GaN on silicon-on-diamond (SOD) development.
NC State Researcher Creates New Material: Magnetic Liquid April 28, 2006 -- Micrograph of a metal-rich, zincchloride-based liquid crystal. Dr. James Martin of NC State's Department of Chemistry is the first researcher to engineer liquid crystals with exceptionally high concentrations of metallic compounds. This discovery has the potential to revolutionize electronic, optic and magnetic products.
NC State Start-Up, Biolex Therapauetics, Reports Positive Results of its Hepatitis C Product Candidate April 27, 2006 -- Biolex Therapeutics announces positive Phase I results for Hepatitis C product candidate -- Locteron. The NC State start-up company is advancing a proprietary pipeline of product candidates for the treatment of hepatitis C under joint development with OctoPlus. Trana Discovery Teams with Former Glaxo Executives to Fight Drug- Resistant Infectious Diseases April 2006 -- Executives with big-company resumes not only bring scores of industry contacts, they can raise a startup's chances of attracting investments. Trana Discovery
founders want to use the executives' experience and connections to expand the business and attract outside investing.
Garden Design Magazine selects NC State sweet potato ornamental as a premiere plant of 2006. March 2006 -- "Sweet Caroline Red" named 7th in the WAY HOT 100!
|
The mission of the Office of Technology Transfer is to move academic discovery to the marketplace resulting in new products, processes, and companies while maximizing the impact of academic research and forging new partnerships to tackle 21st century issues. |
OTT Home NC State Home Contact Us FAQs Customer Service Feedback Talk to the Director
Copyright NCSU, 2007